glp-1 news today oct 2 2025 Analogues Strategic Business Report 2026: Market to Reach $122.3 Billion by 2030 from $45.3 Billion in GLP-1s Are Growing In Popularity

These drugs, while effective for weight loss or controlling diabetes, can trigger rapid changesweight loss, hormonal fluctuations, and this perceived stress on the body can lead to excessive shedding or hair thinning

Download Pep now on the App Store: Take control of your health and make the most of your GLP-1 experience with Pepthe ultimate companion for medication tracking, nutrition, and habit building.

Your Mounjaro prescription includes full patient information leaflets, disposal guidance, and access to our clinical support team for any questions about your treatment

Christine B

In April 2026, the FDA published a formal proposal in the Federal Register to remove semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list, with a public comment period open through June 2026